Skip to main content
AFYAAfya LimitedBuy Wait5.9·$14.87-2.62%
Buy WaitModerate Confidence
Investment thesis

Afya trades at a notably low forward P/E of 6.9x with a near-perfect Piotroski score and three beats in the last four quarters, but soft revenue growth and a momentum profile that has yet to recover above the long-term average require patience at entry.

Thesis pillars

  • Momentum Below Entry ThresholdStable
  • High Quality Franchise MarginsStable
  • Deeply Discounted ValuationStable
  • +2 more pillars — see the Why tab for full reasoning

Full reasoning →

Open full analysis

Afya Limited (AFYA) Stock Analysis

Breakout setup · Inst Constrain edge

Buy WaitVALUE-TRAP 1/5Moderate Confidence

Consumer Defensive · Education & Training Services

Wait for pullback to $13.66. BUY gates pass at $14.87, but analyst target reached - limited upside remaining and weak growth argue for a more patient entry. Engine's entry $13.66 (support + ATR) is the shallowest technical level that clears the 2:1 A.R:R minimum.

Afya Limited operates as a medical education group in Brazil. The company operates in three segments: Undergraduate, Continuing Education, and Medical Practice Solutions. The Undergraduate segment offers educational services through undergraduate courses related to medical... Read more

$14.87+10.2% A.UpsideScore 5.9/10#7 of 18 Education & Training Services
QualityF-score9 / 9FCF yield37.61%
IncomeYield4.29%Payout41.51%sustainable
Entry $13.66(support + ATR)Stop $13.05Target $15.06(resistance)A.R:R -0.3:1
Analyst target$16.56+11.4%9 analysts
$15.06our TP
$14.87price
$16.56mean
$21

Wait for pullback to $13.66. BUY gates pass at $14.87, but analyst target reached - limited upside remaining and weak growth argue for a more patient entry. Engine's entry $13.66 (support + ATR) is the shallowest technical level that clears the 2:1 A.R:R minimum. Chart setup: Golden cross, above all MAs, RSI 66, MACD bullish. Fundamentals strong but target reached (-3.1% upside). Wait for pullback. Score 5.9/10, moderate confidence.

Passes 7/8 gates (positive momentum, clean insider activity, no SEC red flags, news events none recent, earnings proximity 39d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: aggressive.

TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Thu, Aug 13, 202639d to earnings· next earnings call

Thesis

Rewards
Strong earnings beat streak (3/4)
High-quality business
Attractive valuation
Risks
Analyst target reached - limited upside remaining
Weak growth

Key Metrics

P/E (TTM)9.5
P/E (Fwd)7.8
Mkt Cap$1.4B
EV/EBITDA2.2
Profit Mgn20.1%
ROE16.8%
Rev Growth8.2%
Beta0.35
Dividend4.29%
Rating analysts13

Quality Signals

Piotroski F9/9MoatNarrow

Options Flow

P/C1.00neutral
IV68%elevated

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

1 floor-breaker

Growth below the gate floor. Component breakdown shows what dragged the score down.static

Earnings Growth
2.6
Revenue Growth
4.5
GatesA.R:R -0.3=NEGATIVEMomentum 7.4>=5.5Insider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 39d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARBreakoutSuitability: Aggressive
RSI
66 · Neutral
20D MA 50D MA 200D MAGOLDEN CROSSSupport $13.45Resistance $15.37

Price Targets

$13
$14
$15
A.Upside+1.3%
A.R:R-0.3:1

Position Sizing

ConvictionHigh conviction
Suggested %1.1%
Max %2.3%
RegimeSteady

Risk Alerts

! Target reached (-3.1% upside)
! Negative risk/reward — downside exceeds upside

Earnings

B
B
B
M
3/4 beats
Next Earnings2026-08-13 (39d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is AFYA stock a buy right now?

Wait for pullback to $13.66. BUY gates pass at $14.87, but analyst target reached - limited upside remaining and weak growth argue for a more patient entry. Engine's entry $13.66 (support + ATR) is the shallowest technical level that clears the 2:1 A.R:R minimum. Chart setup: Golden cross, above all MAs, RSI 66, MACD bullish. Fundamentals strong but target reached (-3.1% upside). Wait for pullback. Target $15.06 (+1.3%), stop $13.05 (−13.9%), A.R:R -0.3:1. Score 5.9/10, moderate confidence.

What is the AFYA stock price target?

Take-profit target: $15.06 (+10.2% upside). Target $15.06 (+1.3%), stop $13.05 (−13.9%), A.R:R -0.3:1. Stop-loss: $13.05.

What are the risks of investing in AFYA?

Analyst target reached - limited upside remaining; Weak growth.

Is AFYA overvalued or undervalued?

Afya Limited trades at a P/E of 9.5 (forward 7.8). TrendMatrix value score: 7.4/10. Verdict: Buy (Wait for Entry).

What do analysts say about AFYA?

13 analysts cover AFYA with a consensus score of 2.5/5. Average price target: $17.

What does Afya Limited do?Afya Limited operates as a medical education group in Brazil. The company operates in three segments: Undergraduate,...

Afya Limited operates as a medical education group in Brazil. The company operates in three segments: Undergraduate, Continuing Education, and Medical Practice Solutions. The Undergraduate segment offers educational services through undergraduate courses related to medical school, health sciences, and other non-health undergraduate programs, including medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, biomedicine, business administration, accounting, law, civil and industrial engineering, and pedagogy. The Continuing Education segment provides medical education, including residency preparation programs, specialization test preparation, graduate courses in medicine, and digital and in-person professional development for physicians and medical students. The Medical Practice Solutions segment offers clinical decision support platforms, medical practice management software, healthcare financial services, and digital healthcare ecosystem solutions, such as electronic medical records, practice management tools, telemedicine, digital prescriptions, and doctor-patient relationship platforms. This segment also provides a subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. The company also offers educational health and medical imaging; and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. In addition, it offers printed and digital content, as well as an online medical education platform and physicians, healthcare professionals and students. Afya Limited was founded in 1999 and is headquartered in Belo Horizonte, Brazil.

Related stocks: TAL (TAL Education Group) · EDU (New Oriental Education & Techno) · PRDO (Perdoceo Education Corporation) · LAUR (Laureate Education, Inc.) · PXED (Phoenix Education Partners, Inc)
Home Stocks AFYA

Latest news

Latest News

Thelegaladvocate.com41d ago
Thelegaladvocate.com41d ago
Thelegaladvocate.com41d ago
Yahoo Finance48d ago
TradingKey19d ago
TradingKey19d ago
TradingKey20d ago
TradingKey20d ago
The Globe and Mail34d ago
TipRanks6d ago
GuruFocus6d ago
Simplywall.st7d ago
MarketBeat70d agoAnalyst
Thelegaladvocate.com42d ago
Thelegaladvocate.com42d ago
Simplywall.st21d ago
MarketBeat68d agoAnalyst
Moomoo68d agoAnalyst
MarketBeat68d ago
Finance.yahoo.com40d ago
Loading more...